Status:
WITHDRAWN
Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma
Lead Sponsor:
St. Olavs Hospital
Conditions:
Stomach Neoplasms
Eligibility:
All Genders
Phase:
NA
Brief Summary
Preclinical studies at our institution, based on a genetic mouse model of stomach cancer, strongly suggest that innervation of the stomach wall is deeply involved in tumorigenesis of stomach cancer. T...
Eligibility Criteria
Inclusion
- Fifteen patients evaluated- or treated for suspected or verified gastric adenocarcinoma at the Department of Gastrointestinal Surgery, St Olavs Hospital, Trondheim University Hospital
- informed consent
Exclusion
- General contraindications for endoscopy with biopsies (i.e. bleeding disorders or use of anticoagulants).
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01821196
Start Date
December 1 2012
End Date
February 1 2018
Last Update
March 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.